Detalhe da pesquisa
1.
Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real-world findings from NHS England between 2013 and 2019.
BJU Int
; 131(6): 734-744, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680312
2.
Diagnosis, treatment, and survival from kidney cancer: real-world National Health Service England data between 2013 and 2019.
BJU Int
; 132(5): 541-553, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37436368
3.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411939
4.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med
; 19(6): e1003998, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35671327
5.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28578639
6.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Lancet
; 387(10024): 1163-77, 2016 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719232
7.
Immune checkpoint inhibitors in renal cell carcinoma.
Clin Sci (Lond)
; 131(21): 2627-2642, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079639
8.
Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279).
BJU Int
; 116(6): 880-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639506
9.
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
Future Oncol
; 10(2): 219-31, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24490608
10.
Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma.
BMC Urol
; 13: 26, 2013 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23688003
11.
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.
PLoS One
; 17(6): e0269192, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653395
12.
Evidencing the impact of cancer trials: insights from the 2014 UK Research Excellence Framework.
Trials
; 21(1): 486, 2020 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32503612
13.
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.
Eur Urol
; 76(6): 719-728, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31447077
14.
The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers.
Cancer Chemother Pharmacol
; 61(1): 23-32, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17909809
15.
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Eur Urol Oncol
; 1(6): 449-458, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158087
16.
Circulating biomarkers in cancer care: What possible use?
Pract Lab Med
; 7: 45-48, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28856218
17.
Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.
J Clin Oncol
; 35(14): 1530-1541, 2017 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28300506
18.
Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer.
BMJ Open
; 5(10): e007925, 2015 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26482768